Nobel prize in chemistry
Apoaequorin (Pronounced: ā-poe-ē-kwôr-ĭn) was first discovered in 1962 in glowing jellyfish. Turns out these proteins caused the jellyfish to glow when the proteins bound to calcium ions. We’ve learned a lot about how calcium functions in the body by using apoaequorin. The Princeton professor who discovered this protein and his colleagues who helped develop the research won the Nobel prize in 2008. Prevagen does not cause any glowing!
Quincy Bioscience and Apoaequorin
Founded in June of 2004 and based in Madison, Wisconsin, Quincy Bioscience is a biotechnology company focused on the discovery, development, and commercialization of novel technologies to address cognitive issues and other age-related health challenges. The core technology of the company is the innovative application of the calcium-binding protein Apoaequorin. Using this cutting edge protein originally discovered in jellyfish in the early 1960’s, the company focuses on alleviating the consequences of impaired calcium homeostasis (the imbalance of calcium ions) which can lead to mild memory loss associated with aging.
From a Jellyfish
Apoaequorin originally comes from a species of jellyfish called Aequorea victoria — a bioluminescent organism with one of the simplest nervous systems. Quincy Bioscience is the first to utilize apoaequorin as a tool in the support of the brain in the human body.* The Nobel Prize in Chemistry in 2008 was awarded to researchers Osamu Shimomura, Martin Chalfie, and Roger Y. Tsien who discovered the luminescent jellyfish protein and advanced its usefulness in science with the Nobel committee calling the discovering of the glowing protein, “has become one of the most important tools used in contemporary bioscience.” Their discovery and advancement made the work at Quincy Bioscience possible.